Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Julianne O. Darling"'
Autor:
Julianne O. Darling, Farah Raheem, Katelyn C. Carter, Elizabeth Ledbetter, Jennifer F. Lowe, Christopher Lowe
Publikováno v:
Pharmacy, Vol 8, Iss 1, p 46 (2020)
Oral chemotherapy represents a major patient-centric advancement in therapy convenience. However, ownership of safe and correct administration of these agents requires significant patient education. To address this challenge, an in-person pharmacist-
Externí odkaz:
https://doaj.org/article/dda3bedaf08a4ac3933c2c7338ba9c70
Publikováno v:
JCO oncology practice. 18(7)
PURPOSE: As the utilization of oral cancer medications rises, it is vital that cancer centers track costs associated with these expensive medications. This research seeks to report the cost interventions associated with medically integrated pharmacie
Publikováno v:
Targeted Oncology
Cabozantinib is an oral multikinase inhibitor whose targets include vascular endothelial growth factor receptors, MET, and the TAM family of kinases (TYRO3, AXL, MER). Cabozantinib is approved for patients with advanced hepatocellular carcinoma who h
Autor:
Farah Raheem, Katelyn C Carter, Julianne O Darling, Christopher Lowe, Jennifer F Lowe, Elizabeth Ledbetter
Publikováno v:
Pharmacy: Journal of Pharmacy Education and Practice
Pharmacy
Volume 8
Issue 1
Pharmacy, Vol 8, Iss 1, p 46 (2020)
Pharmacy
Volume 8
Issue 1
Pharmacy, Vol 8, Iss 1, p 46 (2020)
Oral chemotherapy represents a major patient-centric advancement in therapy convenience. However, ownership of safe and correct administration of these agents requires significant patient education. To address this challenge, an in-person pharmacist-
Publikováno v:
Targeted Oncology; Aug2020, Vol. 15 Issue 4, p549-565, 17p
Autor:
Darling, Julianne O., Raheem, Farah, Carter, Katelyn C., Ledbetter, Elizabeth, Lowe, Jennifer F., Lowe, Christopher
Publikováno v:
Pharmacy; Mar2020, Vol. 8 Issue 1, p46, 1p